|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.18 USD | -1.06% |
|
+0.35% | +36.67% |
| Market Cap | 140B 122B 114B 105B 197B 13,328B 200B 1,353B 529B 6,610B 524B 512B 22,837B | P/E 2026 * |
17.4x | P/E 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 195B 171B 160B 147B 275B 18,656B 280B 1,893B 741B 9,252B 733B 717B 31,966B | EV / Sales 2026 * |
0.48x | EV / Sales 2027 * | 0.45x |
| Free-Float |
71.2% | Yield 2026 * |
2.43% | Yield 2027 * | 2.51% |
Last Transcript: CVS Health Corporation
| 1 day | -1.04% | ||
| 1 week | +0.26% | ||
| Current month | +4.75% | ||
| 1 month | +4.61% | ||
| 3 months | +29.15% | ||
| 6 months | +45.57% | ||
| Current year | +36.54% |
| 1 week | 105.36 |  | 110 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 61 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.06% | +0.26% | +80.60% | +45.08% | 140B | |
| -2.11% | +10.18% | +18.94% | +50.19% | 92.77B | |
| +1.14% | +3.14% | +6.24% | +57.52% | 28.43B | |
| +0.73% | +12.41% | +40.46% | +74.45% | 26.04B | |
| -0.76% | +32.54% | +65.90% | +246.46% | 22.62B | |
| -0.25% | +11.40% | -8.62% | -19.56% | 22.1B | |
| +1.74% | +4.82% | +66.65% | +138.52% | 15.37B | |
| -2.21% | -2.73% | +2.82% | -6.81% | 14.74B | |
| +1.12% | +2.48% | -3.23% | -7.24% | 13.08B | |
| +0.58% | +2.74% | -12.77% | +87.24% | 11.26B | |
| Average | -0.10% | +6.60% | +25.70% | +66.59% | 38.59B | |
| Weighted average by Cap. | -0.77% | +4.73% | +42.53% | +58.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 359B 335B 308B 577B 39,115B 587B 3,970B 1,554B 19,398B 1,537B 1,504B 67,021B | 427B 374B 349B 321B 601B 40,767B 612B 4,137B 1,619B 20,218B 1,602B 1,567B 69,852B |
| Net income | 8.04B 7.06B 6.57B 6.05B 11.34B 769B 11.53B 78B 30.53B 381B 30.2B 29.55B 1,317B | 9.35B 8.2B 7.64B 7.03B 13.17B 893B 13.4B 90.62B 35.47B 443B 35.09B 34.33B 1,530B |
| Net Debt | 55.76B 48.94B 45.57B 41.92B 78.57B 5,328B 79.92B 541B 212B 2,642B 209B 205B 9,128B | 52.15B 45.77B 42.62B 39.2B 73.48B 4,982B 74.74B 506B 198B 2,471B 196B 192B 8,537B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | US$108.41 | -0.85% | 991,786 |
| 26-07-28 | US$109.34 | +2.12% | 6,682,269 |
| 26-07-27 | US$107.07 | -0.62% | 7,857,618 |
| 26-07-24 | US$107.74 | +0.80% | 5,370,540 |
| 26-07-23 | US$106.89 | -1.10% | 5,823,895 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
